Salts of treprostinil

US9701611B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9701611-B2
Application numberUS-201615359941-A
CountryUS
Kind codeB2
Filing dateNov 23, 2016
Priority dateMar 15, 2013
Publication dateJul 11, 2017
Grant dateJul 11, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are novel treprostinil salts as well as methods for making treprostinil salts.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of synthesizing a treprostinil salt comprising: a) alkylating a compound of formula (1) with an alkylating agent having the following formula: to form a compound of formula (2) wherein X is Cl, Br or I, R is COOR′ and R′ is an alkyl group or substituted or unsubstituted benzyl; and b) hydrolyzing the compound of formula (2) with a hydroxide or a basic salt to form a treprostinil salt, wherein R 1 and R 2 are each H. 2. The method of claim 1 , wherein R′ is a (C1-C6)alkyl. 3. The method of claim 1 , wherein R′ is unsubstituted benzyl. 4. The method of claim 1 , wherein R′ is benzyl substituted at one or more meta, ortho or para positions with one or more substituents selected from the group consisting of —NO 2 , —CN, halogen, (C1-C3)alkyl, halo(C1-C3)alkyl, (C1-C3)alkoxy and halo(C1-C3)alkoxy. 5. The method of claim 1 , wherein said hydrolyzing is performed with a hydroxide selected from the group consisting of ammonia hydroxide and a metal hydroxide. 6. The method of claim 5 , wherein said hydrolyzing is performed with a hydroxide of a Group IA or Group IIA metal. 7. The method of claim 5 , wherein said hydrolyzing is performed with a hydroxide of K, Ca, Mg, Ba, Cs, Li or Na. 8. The method of claim 1 , wherein said hydrolyzing is performed with a carbonate basic salt. 9. The method of claim 8 , wherein the carbonate basic salt is lithium carbonate, potassium carbonate, sodium carbonate, cesium carbonate, calcium carbonate or ammonium carbonate. 10. The method of claim 1 , wherein said alkylating is performed in a polar aprotic solvent. 11. The method of claim 1 , wherein said alkylating is performed in the presence of a base or a base salt. 12. The method of claim 1 , wherein said alkylating is performed in the presence of an alkylating catalyst. 13. The method of claim 12 , wherein the alkylating catalyst is tetrabutyl ammonium bromide, potassium iodide or sodium iodide. 14. The method of claim 1 , further comprising isolating and/or crystallizing the treprostinil salt. 15. The method of claim 14 , wherein a solvent for said isolating and/or crystallizing is the same as a solvent for said hydrolyzing. 16. A method of synthesizing a salt of treprostinil comprising: a) alkylating a compound of formula (1) with an alkylating agent having the following formula: to form a compound of formula (2) wherein X is Cl, Br or I, R is COOR′ and R′ is substituted or unsubstituted benzyl; and b) hydrogenalizing the compound of formula (2) to form treprostinil; and c) reacting the treprostinil with a base or a base salt to form a treprostinil salt, wherein each of R 1 and R 2 is H. 17. The method of claim 16 , wherein R′ is unsubstituted benzyl. 18. The method of claim 16 , wherein R′ is benzyl substituted at one or more meta, ortho or para positions with one or more substituents selected from the group consisting of —NO 2 , —CN, halogen, (C1-C3)alkyl, halo(C1-C3)alkyl, (C1-C3)alkoxy and halo(C1-C3)alkoxy. 19. The method of claim 16 , wherein said reacting comprises reacting the treprostinil with ammonia hydroxide or a metal hydroxide. 20. The method of claim 19 , wherein said reacting comprises reacting the treprostinil with a hydroxide of Group IA or Group IIA metal. 21. The method of claim 19 , wherein said reacting comprises reacting the treprostinil with a hydroxide of K, Ca, Mg, Ba, Cs, Li or Na. 22. The method of claim 16 , wherein said reacting comprises reacting the treprostinil with a carbonate. 23. The method of claim 22 , wherein the carbonate is lithium carbonate, potassium carbonate, sodium carbonate, cesium carbonate, calcium carbonate or ammonium carbonate. 24. The method of claim 16 , wherein said alkylating is performed in a polar aprotic solvent. 25. The method of claim 16 , wherein said alkylating is performed in the presence of a base or a base salt. 26. The method of claim 16 , wherein said alkylating is performed in the presence of an alkylating catalyst. 27. The method of claim 26 , wherein the alkylating catalyst is tetrabutyl ammonium bromide, potassium iodide or sodium iodide. 28. The method of claim 16 , wherein said hydrogenalizing comprises forming a raw mixture comprising the treprostinil and wherein said reacting comprises treating the raw mixture with the base or the base salt. 29. The method of claim 16 , further comprising isolating the treprostinil formed in said hydrogenalizing before said reacting. 30. The method of claim 29 , wherein said isolating comprises forming solid treprostinil by filtering and evaporating a raw mixture formed in said hydrogenalizing. 31. The method of claim 16 , further comprising isolating and/or crystallizing the treprostinil salt. 32. The method of claim 31 , wherein a solvent for said isolating and/or crystallizing is the same as a solvent for said hydrolyzing. 33. The method of claim 32 , wherein the solvent for said isolating and/or crystallizing comprises an organic solvent selected from ethanol, isopropyl alcohol, methanol, acetone, ethyl acetate, hexanes, heptanes, isopropyl acetate, and mixtures thereof. 34. The method of claim 33 , wherein the solvent for said isolating and/or crystallizing comprises ethanol. 35. The method of claim 16 , further comprising converting the treprostinil salt to treprostinil as free acid. 36. The method of claim 35 , further comprising converting the treprostinil as free acid formed from the treprostinil salt into a treprostinil salt. 37. The method of claim 1 , further comprising converting the treprostinil salt to treprostinil as free acid. 38. The method of claim 37 , further comprising converting the treprostinil as free acid formed from the treprostinil salt into a treprostinil salt.

Assignees

Inventors

Classifications

  • C07C51/41Primary

    Preparation of salts of carboxylic acids ({C07C51/093 - C07C51/34 take precedence} preparation of soap C11D) · CPC title

  • by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part · CPC title

  • containing six-membered aromatic rings and other rings · CPC title

  • Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60) · CPC title

  • A61P9/12Primary

    Antihypertensives · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9701611B2 cover?
Provided are novel treprostinil salts as well as methods for making treprostinil salts.
Who is the assignee on this patent?
United Therapeutics Corp
What technology area does this patent fall under?
Primary CPC classification C07C51/41. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).